Pharmicell Co., Ltd. (005690.KS) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 20Aug 25Aug 28Sep 2Sep 7Sep 10Sep 15Sep 18

Key dataSep 18, 2026

OpenKRW 12,200.00

From 52W high−42.81%

Volume10.14M

Market capKRW 694.85B

P/E (TTM)14.9x

P/S (TTM)5.1x

Div yield0.43%

Key dataSep 18, 2026

Open

KRW 12,200.00

From 52W high

−42.81%

Volume

10.14M

Market cap

KRW 694.85B

ValuationView details →

P/E (Fwd)

22.7x

EV/EBITDA

13.9x

P/E (TTM)

14.9x

RSI (14)

65.0

MomentumView details →

1D Return

−0.43%

YTD Return

−13.76%

ValuationView details →

P/E (Fwd)

22.7x

P/E (TTM)

14.9x

EV/EBITDA

13.9x

EV/Sales

4.8x

P/S (TTM)

5.1x

P/B (TTM)

4.8x

ProfitabilityView details →

Gross Margin

44.08%

Net Margin

34.26%

EBITDA Margin

34.57%

ROE (TTM)

32.49%

ROA (TTM)

25.29%

Asset Turnover

0.77x

GrowthView details →

Revenue YoY

+51.28%

EPS YoY

+124.74%

FCF YoY

+30.92%

Revenue CAGR 3Y

+23.75%

EPS CAGR 3Y

+69.58%

EBITDA YoY

+82.18%

MomentumView details →

1D Return

−0.43%

YTD Return

−13.76%

1Y Return

+0.64%

RSI (14)

65.0

vs 50D SMA

+13.73%

vs 200D SMA

−12.74%

Capital & dividendView details →

Debt/Equity

0.18x

Current Ratio

7.15x

Quick Ratio

6.01x

Div Yield

0.43%

Div Rate

KRW 50.00

Div Growth 1Y

+150.00%

EarningsView details →

EPS (Actual)

KRW 172.96

EPS Surprise

−18.80%

Beats (12Q)

0/12

Next Q EPS Est

KRW 236.00

Avg Surprise (4Q)

−9.40%

Rev Surprise

−7.41%

Financials snapshotView financials →

Revenue (TTM)

135.94B

Net Income (TTM)

46.57B

Op. CF (TTM)

41.02B

Next earningsNov 11, 2026 →

Latest newsMore news →

No recent news for 005690.KS.

Similar companies

Onconic Therapeutics476060.KQ Chabiotech Co.,Ltd.085660.KQ GI Innovation, Inc.358570.KQ Medy-Tox Inc.086900.KQ Green Cross Holdings Corporation005250.KS Orum Therapeutics, Inc.475830.KQ Find similar companies →

Latest newsMore news →

No recent news for 005690.KS.